MWM
MRNA icon

Mission Wealth Management’s Moderna MRNA Stock Holding History

Mission Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,045
Closed -$243K – 704
2024
Q2 		$243K Buy
2,045
+8
+0.4% +$1.01K 0.01% 572
2024
Q1 		$217K Sell
2,037
-26
-1% -$2.62K 0.01% 629
2023
Q4 		$205K Buy
+2,063
New +$174K 0.01% 547
2022
Q1 		– Sell
-787
Closed -$200K – 558
2021
Q4 		$200K Buy
787
+95
+14% +$27.8K 0.01% 518
2021
Q3 		$266K Buy
+692
New +$255K 0.01% 441

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mission Wealth Management's MRNA Position: Q3 2024 in Review

Mission Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,045 shares — an estimated $243K sold.

Mission Wealth Management first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $266K in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Mission Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Mission Wealth Management sold 2,045 Moderna shares in Q3 2024, an estimated $243K.
  • Mission Wealth Management first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
  • Mission Wealth Management's Moderna position peaked at $266K in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Mission Wealth Management's 13F filing for Q3 2024, filed 31 Oct 2024.